Drug Company Announces It Will Produce Millions of Mpox Vaccines by Next Year

Shares of vaccine manufacturer Bavarian Nordic saw a spike this week.

This 2003 electron microscope image made available by the Centers for Disease Control and Prevention shows mature, oval-shaped monkeypox virions (L) and spherical immature virions (R) obtained from a sample of human skin associated with the 2003 prairie dog outbreak. Cynthia S. Goldsmith, Russell Regner/CDC via AP

Shares of mpox vaccine maker Bavarian Nordic saw an increase this week after the World Health Organization (WHO) declared a public health emergency and as the company’s CEO announced it could provide 10 million doses of the vaccine.

“We have inventory and we have the capabilities. What we’re missing are the orders,” CEO Paul Chaplin told Bloomberg this week.